What is the appropriate management for a female patient with persistent chest pain after using topical diclofenac gel (Voltaren), Iger balm, and another ointment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Immediate Emergency Department Evaluation Required

This patient requires immediate emergency department evaluation to rule out acute coronary syndrome (ACS) and other life-threatening causes of chest pain. The persistence of chest pain despite topical treatments is a red flag that demands urgent cardiac assessment, not continued home management 1.

Critical Action Steps

1. Activate Emergency Medical Services Immediately

  • Call 9-1-1 for emergency transport to the closest ED 2
  • Do not wait for symptoms to disappear - symptom resolution is a poor indicator of cardiac risk 3
  • Administer aspirin 250-500 mg (fast-acting, chewable) immediately if not contraindicated 3

2. Why This Cannot Be Managed at Home

The application of multiple topical ointments (Voltaren/diclofenac gel, Tiger balm, and another unspecified ointment) suggests the patient has been attempting self-treatment for chest pain. This is dangerous because:

  • Chest pain persisting despite treatment requires cardiac evaluation - approximately 5% of acute chest pain presentations are due to ACS, which can be life-threatening 1
  • Symptoms described as pressure, tightness, heaviness, or burning should be considered indicative of ACS 1
  • NSAIDs like topical diclofenac should not be used for cardiac chest pain and are explicitly contraindicated during hospitalization for ACS due to increased risk of major adverse cardiac events 4

3. What the ED Evaluation Must Include

Upon arrival, the patient needs:

  • 12-lead ECG within 10 minutes to assess for ST-segment elevation or other ischemic changes 1, 5
  • Cardiac troponin levels (preferably troponin T or I) at presentation and repeated at 6-12 hours 5
  • Assessment for high-risk features including:
    • Signs of reduced cardiac output (tachycardia, hypotension, altered mental status)
    • Signs of heart failure (pulmonary edema, elevated jugular venous pressure)
    • Hemodynamic instability 1

4. Critical Pitfall: Topical NSAIDs and Cardiac Pain

Voltaren (diclofenac) gel is FDA-approved only for arthritis pain in joints (hands, wrists, elbows, knees, ankles, feet) - NOT for chest pain 6. The FDA label explicitly warns:

  • NSAIDs increase risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke
  • These events can occur early in treatment and increase with duration of use
  • NSAIDs should not be initiated and should be discontinued during hospitalization for ACS 4

The fact that this patient applied topical diclofenac to the chest (an off-label use) and pain persisted strongly suggests:

  1. The pain is NOT musculoskeletal
  2. Cardiac etiology must be ruled out urgently

5. Additional Concerns About Multiple Topical Products

The FDA label for Voltaren gel specifically warns against using it with other topical products (including other ointments, lotions, or medications) on the same skin site due to potential altered absorption and tolerability 6. The combination of Voltaren, Tiger balm, and another ointment creates:

  • Unpredictable systemic absorption
  • Potential for increased adverse effects
  • Possible skin irritation masking underlying serious pathology

6. What Should NOT Happen

Do not:

  • Continue topical treatments and observe at home
  • Assume this is musculoskeletal pain because topical NSAIDs were tried
  • Delay evaluation because the patient is female (women are at risk for underdiagnosis of cardiac causes) 2, 7
  • Use response to nitroglycerin as a diagnostic criterion - relief with nitroglycerin is not necessarily diagnostic of myocardial ischemia 2

7. Special Considerations for Female Patients

If this patient is female, heightened vigilance is required because:

  • Women presenting with chest pain are at risk for underdiagnosis 2
  • Women may present with accompanying symptoms more commonly than classic chest pain (dyspnea, nausea, fatigue) 2
  • Women are more likely to have myocardial infarction with non-obstructive coronary arteries (MINOCA) 7

Bottom Line

Stop all topical treatments immediately and proceed directly to the emergency department. Persistent chest pain after attempting self-treatment with topical agents is a medical emergency requiring immediate cardiac evaluation with ECG and troponin testing. The use of topical NSAIDs for chest pain is inappropriate and potentially dangerous, as it may delay recognition of life-threatening cardiac conditions 1, 4, 1.

References

3
Guideline

task force on the management of chest pain.

European Heart Journal, 2002

Related Questions

How frequently can I use Uniren spray (diclofenac topical spray)?
Is it normal to apply Voltaren (diclofenac) topically to both legs like a lotion?
Can you use topical Diclofenac with oral Acetaminophen (Tylenol)?
What concentration of diclofenac (Voltaren) gel is recommended for a middle-aged or older adult patient with a bone spur and no history of gastrointestinal or cardiovascular disease?
Is Voltaren (diclofenac) gel appropriate for treating lumbar spine osteoarthritis?
A 59-year-old woman requires chemical prophylaxis for deep‑vein thrombosis and is currently taking rivaroxaban (Xarelto) 20 mg daily at home; her labs show markedly elevated transaminases (AST 288 U/L, ALT 217 U/L), low albumin (1.8 g/dL), and anemia (hemoglobin 9.5 g/dL) with otherwise normal renal function. What is the appropriate anticoagulant strategy for DVT prophylaxis in this patient?
What is the best short-acting stimulant to add to an existing once-daily lisdexamfetamine (Vyvanse) regimen?
In a conscious patient with known coronary artery disease on non‑invasive ventilation receiving a furosemide infusion who has hyperkalemia and a blood pressure of 110/53 mmHg, what is the next step if the heart rate begins to drop?
What is the appropriate treatment for increased throat mucus in a patient with Sjögren’s syndrome?
How should I manage a patient with new‑onset confusion, a Foley catheter, cloudy urine, and abdominal pain suggestive of a catheter‑associated urinary tract infection?
What is the appropriate management for a newborn with clinical jaundice and a total serum bilirubin of 2.6 mg/dL at 24 hours of life, which is below the phototherapy threshold?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.